Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Selective and Nonselective Cyclooxygenase Enzyme Inhibition on Arterial Blood Pressure and Cerebral Blood Flow With Exposure to Intermittent Hypoxia in Humans

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Marc Poulin, University of Calgary
ClinicalTrials.gov Identifier:
NCT01280006
First received: January 18, 2011
Last updated: December 2, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
No publications provided by University of Calgary

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):